Search results
Showing 6361 to 6375 of 7680 results
Health app: ChatHealth communication platform in school nursing services (MIB130)
The health app briefing on ChatHealth communication platform in school nursing services has been withdrawn.
This medtech innovation briefing has been updated and replaced by NICE's early value assessment guidance on Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies.
Artificial intelligence for analysing chest X-ray images (MIB292)
This medtech innovation briefing has been updated and replaced by health technology evaluation guidance on artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12).
Daylight for treating generalised anxiety disorder in adults (MIB309)
August 2023: This medtech innovation briefing (MIB) has been withdrawn at the company’s request as the evidence for the technology has moved on and the company expect to seek a NICE guidance output in due course.
Erythrocyte encapsulated asparaginase for treating acute lymphoblastic leukaemia [ID864]
Discontinued [GID-TA10047]
Abicipar pegol for treating wet age-related macular degeneration ID1533
In development [GID-TA10511] Expected publication date: TBC
Durvalumab for treating metastatic urothelial bladder cancer after chemotherapy [ID1172]
Discontinued [GID-TA10394]
Bevacizumab for untreated malignant pleural mesothelioma [ID1183]
Discontinued [GID-TA10197]
Discontinued [GID-TA10149]
Atezolizumab in combination for untreated squamous non-small-cell lung cancer [ID1481]
Discontinued [GID-TA10546]
Depatuxizumab mafodotin in combination for untreated EGFR-amplified glioblastoma multiforme [ID1466]
Discontinued [GID-TA10355]
Clofarabine for treating acute lymphoblastic leukaemia in children after 2 therapies [ID1033]
Discontinued [GID-TA10081]
Nelarabine for treating refractory T-cell lymphoblastic non-Hodgkin's lymphoma [ID1044]
Discontinued [GID-TA10087]